These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 11076495)

  • 21. The prospects for "preventing" Down's syndrome in an English region.
    Forster DP
    Rev Epidemiol Sante Publique; 1980 Dec; 28(4):423-30. PubMed ID: 6452660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genetic counseling and prenatal diagnosis in Down's syndrome].
    Papp Z
    Orv Hetil; 1974 May; 115(19):1103-6. PubMed ID: 4274931
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prenatal screening for Down's syndrome by measuring the AFP concentration in the maternal serum].
    Veress L; Szabó M; Polgár K; Takács L; Papp Z
    Orv Hetil; 1988 Jul; 129(31):1677. PubMed ID: 2476703
    [No Abstract]   [Full Text] [Related]  

  • 24. Ethical issues in prenatal diagnosis.
    Johnson SR; Elkins TE
    Clin Obstet Gynecol; 1988 Jun; 31(2):408-17. PubMed ID: 3402114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
    DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
    N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down's syndrome: cost, quality and value of life.
    Alderson P
    Soc Sci Med; 2001 Sep; 53(5):627-38. PubMed ID: 11478542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.
    Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K
    Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prenatal diagnostics and information to parents].
    de la Fuente Hontañón C
    Cuad Bioet; 2009; 20(70):423-40. PubMed ID: 19799482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Noninvasive prenatal genetic diagnosis: a bioethical reflection on the use of noninvasive prenatal diagnosis from the analysis of nucleic acids present in maternal peripheral blood].
    González-Melado FJ; Di Pietro ML
    Cuad Bioet; 2011; 22(74):49-75. PubMed ID: 21692554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethical concerns and future directions in maternal screening for Down syndrome.
    Elkins TE; Brown D
    Womens Health Issues; 1995; 5(1):15-20. PubMed ID: 7742644
    [No Abstract]   [Full Text] [Related]  

  • 31. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the perspective of midwives involved in offering serum screening for Down's syndrome in Northern Ireland.
    McNeill J; Alderdice F
    J Clin Nurs; 2009 Oct; 18(20):2888-96. PubMed ID: 19619213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal screening, ethics and Down's syndrome: a literature review.
    Alderson P
    Nurs Ethics; 2001 Jul; 8(4):360-74. PubMed ID: 16004090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Women and health care professionals' preferences for Down's Syndrome screening tests: a conjoint analysis study.
    Bishop AJ; Marteau TM; Armstrong D; Chitty LS; Longworth L; Buxton MJ; Berlin C
    BJOG; 2004 Aug; 111(8):775-9. PubMed ID: 15270923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal screening: professional standards and the limits of parental choice.
    Botkin JR
    Obstet Gynecol; 1990 May; 75(5):875-80. PubMed ID: 2109295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics, amniocentesis, and abortion.
    Hirschhorn K
    Mt Sinai J Med; 1984; 51(1):15-7. PubMed ID: 6608672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The "new genetics": an ethical perspective from family practice.
    Sugiyama J
    Can Fam Physician; 1988 Apr; 34():941-4. PubMed ID: 11660316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethical considerations of early (first vs. second trimester) risk assessment disclosure for trisomy 21 and patient choice in screening versus diagnostic testing.
    Sharma G; McCullough LB; Chervenak FA
    Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):99-104. PubMed ID: 17299736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Doctor, what would you do in my position?' Health professionals and the decision-making process in pregnancy monitoring.
    Hertig SG; Cavalli S; Burton-Jeangros C; Elger BS
    J Med Ethics; 2014 May; 40(5):310-4. PubMed ID: 23543803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.